An interventional study of App-based diabetes management and community-based health coaching in Diabetes Mellitus Type 2, sponsored by Singapore General Hospital. Recruiting at 2 sites in Singapore. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2025-02-25.
Sponsored by Singapore General Hospital · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Diabetes Mellitus, Type 2 by Singapore General Hospital — 5 open to participants now, 8 under way, none of them phase 3. Diabetes Mellitus, Type 2 · Singapore General Hospital.
Among the 15 studies in Diabetes Mellitus, Type 2 by Singapore General Hospital, this one is the 7th largest by planned enrollment of the 13 interventional ones that give a count, is one of 2 that started in 2024, is one of 13 with no phase, and was the 14th registered.
10,403 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.
Browse Diabetes Mellitus, Type 2 studies →5 of the 15 studies in Diabetes Mellitus, Type 2 by Singapore General Hospital are open now, in 1 country. Recruiting first, the newest first:
Singapore General Hospital · Sites in Singapore
Ages 21–100
Singapore General Hospital · Sites in Singapore
Ages 21–100
Singapore General Hospital · Sites in Singapore
Ages 40–75
Singapore General Hospital · Sites in Singapore
Ages 21–70
By country, each count listing its studies:
Of the 882 Diabetes Mellitus, Type 2 studies recruiting now, 372 (42%) set no upper age limit and 384 (44%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.
This study: 21 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 2 started in 2024.
This study's planned enrollment of 150 is above the median of 80 across 8,372 interventional studies indexed under Diabetes Mellitus, Type 2.
Median enrollment 150 across the 13 interventional studies, 386 across the 2 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Singapore General Hospital is the lead sponsor of 270 studies on the registry; 57 are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 15 studies in Diabetes Mellitus, Type 2 by Singapore General Hospital, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Community-based health coaching interventions play a vital role in complementing the traditional chronic disease management model for type 2 diabetes patients. Compared to conventional approaches that often focus on periodic clinical visits, community-based coaching could provide continuous, personalised support within patients in everyday environments. Health coaches work directly with patients to set realistic goals, develop individualised action plans, and provide ongoing motivation and accountability. This personalised attention helps to improve self-management skills, such as medication adherence, dietary choices, and physical activity, which are crucial for chronic disease management and preventing complications. Our mobile health app, EMPOWER+ has multiple logging features, gamified elements to help users set goals and provide rewards, educational resources, and personalised nudges generated based on real users; inputs and predictive modeling. It has demonstrated some preliminary effectiveness and acceptability within the clinical settings. This trial aims to assess its effectiveness, adoption, and sustainability in the less-controlled community settings, preparing for its large implementation in the future.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
HbA1c
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Behavioral: App-based diabetes management and community-based health coaching
All participants will use the EMPOWER+ app and a Fitbit wearable. They will also received community-based health coaching and/or other prescribed structured programmes.
HbA1c
HbA1c over 6 months
Time frame: 6 months
Physical activity as measured by number of steps
Physical activity over 6 months
Time frame: 6 months
Physical activity as measured by moderate to vigorous active minutes
Physical activity over 6 months
Time frame: 6 months
Physical activity as measured by GPAQ
Physical activity as measured by GPAQ
Time frame: 6 months
Patient activation score as measured by patient activation measure
Difference in patient activation score between intervention and control over 6 months
Time frame: 6 months
Medication adherence as measured by MARS-5
Difference in medication adherence between intervention and control over 6 months
Time frame: 6 months
Quality of life as measured by EQ-5D-5L
Difference in quality of life between intervention and control over 6 months
Time frame: 6 months
Healthcare cost as measured by cost of consultations, lab tests, medications, admission
Healthcare cost over 6 months
Time frame: 6 months
Healthcare cost as measured by WPAI
Healthcare cost over 6 months
Time frame: 6 months
Maintenance of the intervention effects on HbA1c
HbA1c over 6 months after the 6-month intervention
Time frame: 6 months
Maintenance of the intervention effects on blood pressure
Blood pressure over 6 months after the 6-month intervention
Time frame: 6 months
Maintenance of the intervention effects on total cholesterol
Total cholesterol over 6 months after the 6-month intervention
Time frame: 6 months
Maintenance of the intervention effects on high-density lipoprotein (HDL)
HDL over 6 months after the 6-month intervention
Time frame: 6 months
Maintenance of the intervention effects on low-density lipoprotein (LDL)
LDL over 6 months after the 6-month intervention
Time frame: 6 months
Maintenance of the intervention effects on triglycerides
Triglycerides over 6 months after the 6-month intervention
Time frame: 6 months
Started Jan 2024 (actual). Primary completion is estimated for Dec 2025, 23 months after the start.
Of 2,078 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 23 months is close to that.
Counting every sponsor, half of 2,255 studies reached it within 21 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.